Activated CD4+and CD8+T Cell Proportions in Multiple Sclerosis Patients

被引:15
|
作者
Arneth, Borros [1 ,2 ]
机构
[1] Justus Liebig Univ Giessen, Univ Hosp Giessen & Marburg, Inst Lab Med & Pathobiochem, Mol Diagnost, Feulgenstr 12, D-35392 Giessen, Germany
[2] Tech Univ Dresden, Inst Clin Chem & Lab Med, Fetscherstr 74, D-01307 Dresden, Germany
关键词
multiple sclerosis; T lymphocytes; CD4+T helper cells; CD8+cytotoxic T cells; CD8(+) T-CELLS; CEREBROSPINAL-FLUID; TREATED PATIENTS; FINGOLIMOD; KINETICS; RATIO;
D O I
10.1007/s10753-016-0441-0
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The goal of this study was to trace the course of multiple sclerosis (MS) by evaluating the lymphocyte subpopulation counts and the levels of CD4+ and CD8+ T cell activation using flow cytometry. Samples obtained from healthy subjects (N = 40) and patients with MS (N = 290) were analyzed. Lymphocytes were labeled for the surface markers CD4+, CD8+, CD3+, CD16+, CD19+, CD45+, and CD53+ and the activation marker HLA-DR+. Cell counts were then determined using flow cytometry. A high degree of inter-individual variability was observed in the counts of all lymphocyte subtypes in the MS group. A significantly lower proportion of CD3+ T cells (69 +/- 14 % in healthy subjects and 60 +/- 17 % as a percent of total lymphocytes in MS patients), CD4+ T cells (41 +/- 11 and 28 +/- 18 %, respectively), and a significantly higher proportion of NK T cells (12 +/- 5 and 25 +/- 21 %, respectively) were observed in patients with MS than in healthy subjects. These differences led to a lowered CD4+/CD8+ T cell ratio. Furthermore, a significantly lower proportion of activated CD4+ T cells (HLA-DR+ CD4+; from 48 +/- 10 to 38 +/- 15 % as a percent of CD4+ cells) was observed in patients with MS than in healthy subjects. The high level of inter-individual variability in lymphocyte cell counts and the counts of activated T cells suggest that MS is a complex and heterogeneous disease.
引用
收藏
页码:2040 / 2044
页数:5
相关论文
共 50 条
  • [1] Activated CD4+ and CD8+ T Cell Proportions in Multiple Sclerosis Patients
    Borros Arneth
    Inflammation, 2016, 39 : 2040 - 2044
  • [2] Study of activation-induced cell death in CD4+and CD8+T lymphocytes from multiple sclerosis patients
    Moreno, M.
    Negrotto, L.
    Rio, J.
    Moubarak, R.
    Comella, J. X.
    Vidal-Jordana, A.
    Perez-Boza, J.
    Montalban, X.
    Comabella, M.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 146 - 146
  • [3] DNA methylation differences in CD4+and CD8+T cells of multiple sclerosis patients and healthy controls
    Brorson, I. S.
    Rhead, B.
    Quach, H.
    Berg-Hansen, P.
    Berge, T.
    Harbo, H. F.
    Bos, S. D.
    Barcellos, L. F.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2018, 26 : 718 - 719
  • [4] Increased CD4+and CD8+T cell differentiation in old melanoma patients
    Seidel, J. A.
    Riddell, N.
    Henson, S.
    Vukmanovic-Stejic, M.
    Rustin, M.
    Nestle, F.
    Lacy, K. E.
    Akbar, A. N.
    IMMUNOLOGY, 2012, 137 : 611 - 611
  • [5] SLFN12 is differentially methylated in multiple sclerosis CD4+and CD8+T cells
    Brorson, I. S.
    Rhead, B.
    Berge, T.
    Adams, C.
    Quach, H.
    Moen, S. M.
    Berg-Hansen, P.
    Celius, E. G.
    Sangurdekar, D. P.
    Bronson, P. G.
    Lea, R. A.
    Burnard, S.
    Maltby, V. E.
    Scott, R. J.
    Lechner-Scott, J.
    Harbo, H. F.
    Bos, S. D.
    Barcellos, L. F.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 592 - 592
  • [6] Understanding progression in multiple sclerosis through transcriptomics and DNA methylation in CD4+and CD8+T cells
    Fernandes, S.
    Morikawa, H.
    Ewing, E.
    Ruhrmann, S.
    Karanthanasis, N.
    Lagani, V.
    Tsamardinos, I.
    Kockum, I.
    Olsson, T.
    Piehl, F.
    Jagodic, M.
    Tegner, J.
    Gomez-Cabrero, D.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 189 - 190
  • [7] PROCESS OPTIMIZATION FOR CD4+AND CD8+T CELL FORMULATION AND CRYOPRESERVATION
    Abazari, A.
    Stevens, S. D.
    Hawkins, B. J.
    Mathew, A.
    Castelli, L.
    CYTOTHERAPY, 2019, 21 (05) : S42 - S42
  • [8] Distinct subsets of CD4+and CD8+T cells in patients with squamous cell carcinoma
    Mamede Da Silva Alves, R.
    Marcato Dalboni, T.
    Da Silva, A. L.
    Vieira, N.
    Santos, P. S. D. S.
    Silva, L. F. F. D.
    Campanelli, A. P.
    SWISS MEDICAL WEEKLY, 2022, 152 : 21S - 21S
  • [9] Role of CD4+and CD8+T cell responses against JC virus in patients with PML
    Gheuens, Sarah
    Bord, Evelyn
    Kesari, Santosh
    Simpson, David M.
    Gandhi, Rajesh T.
    Clifford, David B.
    Berger, Joseph R.
    Koralnik, Igor J.
    JOURNAL OF NEUROVIROLOGY, 2010, 16 : 34 - 35
  • [10] High CD4+and CD8+T-cell response to varicella zoster virus in patients with multiple sclerosis
    Perez Saldivar, Miriam Patricia
    Ordonez, G.
    Pineda, B.
    Sotelo, J.
    Martinez Palomo, A.
    Espinosa, M.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 (01) : 150 - 150